Matches in Wikidata for { <http://www.wikidata.org/entity/Q97899109> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q97899109 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97899109 description "scientific article published on 27 July 2020" @default.
- Q97899109 description "wetenschappelijk artikel" @default.
- Q97899109 description "наукова стаття, опублікована 27 липня 2020" @default.
- Q97899109 name "Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial" @default.
- Q97899109 name "Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial" @default.
- Q97899109 type Item @default.
- Q97899109 label "Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial" @default.
- Q97899109 label "Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial" @default.
- Q97899109 prefLabel "Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial" @default.
- Q97899109 prefLabel "Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial" @default.
- Q97899109 P1433 Q97899109-3B77A81C-F782-4FCB-9F11-5CFACFEA6E9F @default.
- Q97899109 P1476 Q97899109-F2169AB6-B018-4B12-AF8D-90C38659D87E @default.
- Q97899109 P2093 Q97899109-1CEDAA33-1CF0-455E-9037-8F9C98337C51 @default.
- Q97899109 P2093 Q97899109-1EAC51B5-C938-452A-B9B6-F41F2E341385 @default.
- Q97899109 P2093 Q97899109-231DABB7-2194-4C24-9460-24ED0C392173 @default.
- Q97899109 P2093 Q97899109-294A86B4-D52C-4757-8C4B-1FEC6B9CDA6E @default.
- Q97899109 P2093 Q97899109-35C80A6D-761A-45A6-882E-244823DB1C09 @default.
- Q97899109 P2093 Q97899109-3A23D140-A034-45D0-80BF-A59F89FA6BEB @default.
- Q97899109 P2093 Q97899109-4200D533-479B-486D-AA1A-54562BD038BE @default.
- Q97899109 P2093 Q97899109-4EE956E0-897F-4012-A18D-A776E376B7B0 @default.
- Q97899109 P2093 Q97899109-57C54244-38A7-413A-BCAA-EB06F7E60959 @default.
- Q97899109 P2093 Q97899109-7D5C5BEE-A8A2-44E6-9434-2182C4259BFA @default.
- Q97899109 P2093 Q97899109-B9E77823-9ACA-468A-8490-342A66E2FB82 @default.
- Q97899109 P2093 Q97899109-C3091433-31F5-4BB7-A144-9759BB57E761 @default.
- Q97899109 P2093 Q97899109-C4B2D5B3-A99A-4B56-BE64-79E172C1F6F6 @default.
- Q97899109 P2093 Q97899109-CA678C3B-9A75-4F58-907E-9282C69FC42B @default.
- Q97899109 P2093 Q97899109-E10516DF-E53A-45D7-801A-38C95CC01456 @default.
- Q97899109 P2093 Q97899109-E32006EC-AC9C-412F-BF62-752EE6818953 @default.
- Q97899109 P2093 Q97899109-ED150A2C-00DC-4F87-89C4-223A82389A2D @default.
- Q97899109 P304 Q97899109-6F3A68B6-C0BF-4305-85DB-E34B947C792E @default.
- Q97899109 P31 Q97899109-F5B08E0D-FDB3-42E4-A148-04AB268ED63F @default.
- Q97899109 P356 Q97899109-CB6FA43D-1146-458B-B1E2-76D1029C597C @default.
- Q97899109 P50 Q97899109-27A97E62-8A94-49B3-97AC-E220B26A28A6 @default.
- Q97899109 P50 Q97899109-9D2AB1E5-F136-4CBD-96BF-43229144A712 @default.
- Q97899109 P50 Q97899109-DBFAECB0-21E3-45F7-A4FA-DFA2FF0A0695 @default.
- Q97899109 P577 Q97899109-9CD305B8-B698-4C16-AEC4-97598587D59F @default.
- Q97899109 P698 Q97899109-29568AAB-C60F-4E8A-B71E-65C024A33870 @default.
- Q97899109 P921 Q97899109-B059C497-75B5-41F6-835F-A09F060C53A7 @default.
- Q97899109 P356 2047487320941987 @default.
- Q97899109 P698 32718237 @default.
- Q97899109 P1433 Q2493290 @default.
- Q97899109 P1476 "Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial" @default.
- Q97899109 P2093 "Alexander Parkhomenko" @default.
- Q97899109 P2093 "Andreas M Zeiher" @default.
- Q97899109 P2093 "Deepak L Bhatt" @default.
- Q97899109 P2093 "Doron Zahger" @default.
- Q97899109 P2093 "Gregory G Schwartz" @default.
- Q97899109 P2093 "Hung-Fat Tse" @default.
- Q97899109 P2093 "Marie T Baccara-Dinet" @default.
- Q97899109 P2093 "Michael Szarek" @default.
- Q97899109 P2093 "ODYSSEY OUTCOMES Committees and Investigators" @default.
- Q97899109 P2093 "Ph Gabriel Steg" @default.
- Q97899109 P2093 "Qian H Li" @default.
- Q97899109 P2093 "Rafael Diaz" @default.
- Q97899109 P2093 "Robert Pordy" @default.
- Q97899109 P2093 "Shaun G Goodman" @default.
- Q97899109 P2093 "Takeshi Kimura" @default.
- Q97899109 P2093 "Vera A Bittner" @default.
- Q97899109 P2093 "Željko Reiner" @default.
- Q97899109 P304 "2047487320941987" @default.
- Q97899109 P31 Q13442814 @default.
- Q97899109 P356 "10.1177/2047487320941987" @default.
- Q97899109 P50 Q1587897 @default.
- Q97899109 P50 Q64684757 @default.
- Q97899109 P50 Q64858750 @default.
- Q97899109 P577 "2020-07-27T00:00:00Z" @default.
- Q97899109 P698 "32718237" @default.
- Q97899109 P921 Q266018 @default.